NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Tuesday that its first quarter revenues fell 53 percent year over year.

For the three months ended March 31, the San Diego-based liquid biopsy firm logged $806,943 in revenues compared to $1.7 million a year ago. Q1 revenues included about $762,000 in commercial test revenues and $45,000 in development services test revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.